Nova Leap HealthTSXV:NLH 53 Market Cap is C$33.18 Mil as of Jul. 12, 2026. GuruFocus rates TSXV:NLH with a GF Score™ of 53/100 and a GF Value™ of C$0.32 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 697 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 73.31% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nova Leap Health's share price for the quarter that ended in Mar. 2026 was C$0.35. Nova Leap Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 87.31 Mil. Therefore, Nova Leap Health's market cap for the quarter that ended in Mar. 2026 was C$30.56 Mil.
Nova Leap Health's quarterly market cap
declined
from Sep. 2025 (C$27.50 Mil) to Dec. 2025 (C$24.45 Mil) but then
increased
from Dec. 2025 (C$24.45 Mil) to Mar. 2026 (C$30.56 Mil).
Nova Leap Health's annual market cap
declined
from Dec. 2023 (C$25.86 Mil) to Dec. 2024 (C$23.57 Mil) but then
increased
from Dec. 2024 (C$23.57 Mil) to Dec. 2025 (C$24.45 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nova Leap Health's Enterprise Value for Today is C$34.91 Mil.
Nova Leap Health (TSXV:NLH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nova Leap Health Market Cap Related Terms
Nova Leap Health Market Cap Historical Data
* Premium members only.
The historical data trend for Nova Leap Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nova Leap Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nova Leap Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova Leap Health (TSXV:NLH) has a Market Cap of C$33.18 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #511 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 73.3%.
Is Nova Leap Health's Market Cap too high?
Nova Leap Health's current Market Cap is C$33.18 Mil. Based on the distribution chart, Nova Leap Health ranks #511 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nova Leap Health has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #511 out of 697 companies for Market Cap. This places Nova Leap Health in the lower half of its industry. The industry median Market Cap is 102.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 102.47, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 102.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Market Cap is C$33.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (TSXV:NLH) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.32, compared to a current price of C$0.38 — trading 18.8% above its estimated fair value. The current Market Cap is C$33.18 Mil. Nova Leap Health's overall GF Score™ is 53/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nova Leap Health (TSXV:NLH), the current Market Cap is C$33.18 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (TSXV:NLH) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of C$0.38 is trading 18.8% above its estimated GF Value™ of C$0.32.
GuruFocus considers Nova Leap Health to be Modestly Overvalued.
Key valuation signals for TSXV:NLH:
Market Cap: C$33.18 Mil
GF Value™: C$0.32 vs. price of C$0.38 (18.8% above fair value)
No single metric tells the full story. See the TSXV:NLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
53GF Score
Get the complete analysis for TSXV:NLH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NLH has been successfully added to your 
